DrugInfoSys

Meropenem

Drug #922

Meropenem is an intravenous broad spectrum antibiotic derived from thienamycin. The actions, uses and adverse effects are similar to those of imipenem but unlike imipenem it does not need the addition of Cilastatin to prolong its action. It has a slightly greater activity against gram-negative aerobes and slightly less activity against gram positive anaerobes. Antibiotics require constant drug level in body for therapeutic effect. This is attained by taking the medicine at regular intervel of time throughout the day and night as prescribed.

Primary Characteristics

It is of Semi Synthetic origin and belongs to Beta Lactum.

It belongs to Peptidoglycan synthesis inhibitor pharmacological group on the basis of mechanism of action and also classified in Antibiotics pharmacological group.

Molecular Weight: 437.5 · pKa: 2.9, 7.8 · Solubility in Water: sparingly soluble · Solubility in Alcohol: very slightly soluble · Non-proprietary name: Meropenem.

Molecular structure of Meropenem

Pharmacokinetics

Distribution: Meropenem has a volume of distribution is 0.3-0.4 l/kg. plasma protein binding is 2-12%.

Elimination: plasma half-life is 1-1.5 hr, renal excretion is 70%.

Advertisement

Indications

Contraindications

Meropenem is contraindicated in conditions like GI diseases, Hypersensitivity.

Dosage

Meropenem's dosage details are as follows:

DoseSingle DoseFrequencyRouteInstructions
Adult Dosage
750 mg750 mgEvery 8hIVAs required For meningitis
Paediatric Dosage (20kg)
40 mg/kg40 mg/kgFor meningitis
20 mg/kg20 mg/kgIntra VenousFor Paeds of all Ages
Neonatal Dosage (3kg)
7.142 mg/kg7.142 mg/kgEvery 8hIntra Venous As required

Drug Interactions

Unknown2 interactions

Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Side Effects

Meropenem in overdosage may give rise to further complications which include Pseudomembranous colitis , Thrombocytopenia , Stevens johnson syndrome , Stevens johnson syndrome , Eosinophilia , Eosinophilia , Seizures .

Meropenem produces potentially life-threatening effects which include Hypersensitivity reactions. Careful monitoring is needed with proper medical management.

Meropenem is known to cause more or less tolerable side effects which are usually transient. These include Abdominal pain, Constipation , Dermatitis, Diarrhea, Elevation of liver enzymes, Fever, Headache, Nausea, Pruritus , Rashes , Reaction at injection site, Urticaria, Vomiting .

Warnings / Precautions

Pseudomembranous colitis and hypersensitivity reactions have occured and often require immediate drug discontinuation, thrombocytopenia has been reported in patients with significant renal dysfunction, seizures have occurred in the patient with underlying neurological disorders (less frequent than with meropenem, safety and efficacy of meropenem have not been established for children < 3 months of age ; superinfection possible with long courses of therapy.

Interference in Pathology

Meropenem may interfere in the diagnosis of Positive Coombs Test .

Available Brands

Click on a strength to view available brands.

Single Ingredient

Storage Conditions

Meropenem should be stored Inj.

Drug Classification

  1. 1.6.2.1.4Other inhibitors of cell wall synthesis

Manufacturers